{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:07:35Z","timestamp":1761959255561,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T00:00:00Z","timestamp":1585440000000},"content-version":"vor","delay-in-days":88,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.rmcr.2020.101050","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T02:02:33Z","timestamp":1585965753000},"page":"101050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Rapid onset of effect of benralizumab on respiratory symptoms in a patient with eosinophilic granulomatosis with polyangiitis"],"prefix":"10.1016","volume":"30","author":[{"given":"Angelo","family":"Coppola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisstopher Richard","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2020.101050_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"Revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmcr.2020.101050_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"20","key":"10.1016\/j.rmcr.2020.101050_bib3","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmcr.2020.101050_bib4","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2147\/TCRM.S159949","article-title":"Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy","volume":"14","author":"Faverio","year":"2018","journal-title":"Therapeut. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.rmcr.2020.101050_bib5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jaci.2010.04.022","article-title":"IL-5 pathway inhibition in the treatment of asthma and Churg-Strauss syndrome","volume":"125","author":"Rosenwasser","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmcr.2020.101050_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.alit.2019.04.006","article-title":"Decrease in MPO-ANCA after administration of benralizumab in eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Takenaka","year":"2019","journal-title":"Allergol. Int."},{"key":"10.1016\/j.rmcr.2020.101050_bib7","doi-asserted-by":"crossref","first-page":"212580","DOI":"10.7573\/dic.212580","article-title":"Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?","volume":"8","author":"Menzella","year":"2019","journal-title":"Drugs Context"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007120300381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007120300381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:03:22Z","timestamp":1761959002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007120300381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":7,"alternative-id":["S2213007120300381"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2020.101050","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid onset of effect of benralizumab on respiratory symptoms in a patient with eosinophilic granulomatosis with polyangiitis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2020.101050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101050"}}